PRX-08066
PRX-08066 is a drug that is currently under investigation for its potential use in the treatment of pulmonary arterial hypertension. It is a selective 5-HT2B receptor antagonist, which means it works by blocking the action of serotonin on the 5-HT2B receptors. This is believed to reduce the growth of smooth muscle cells in the walls of the arteries in the lungs, which can help to reduce the symptoms of pulmonary arterial hypertension.
Mechanism of Action[edit | edit source]
PRX-08066 works by selectively blocking the 5-HT2B receptor. This receptor is found in high concentrations in the smooth muscle cells of the pulmonary arteries. When these receptors are activated by serotonin, they can stimulate the growth of these cells. This can lead to the thickening of the walls of the arteries, which can increase the pressure in the arteries and make it harder for the heart to pump blood through the lungs. By blocking the action of serotonin on these receptors, PRX-08066 can help to reduce the growth of these cells and alleviate the symptoms of pulmonary arterial hypertension.
Clinical Trials[edit | edit source]
PRX-08066 has been tested in several clinical trials to assess its safety and efficacy in the treatment of pulmonary arterial hypertension. These trials have shown promising results, with patients treated with PRX-08066 showing improvements in exercise capacity and reductions in pulmonary artery pressure. However, further research is needed to confirm these findings and to determine the optimal dosing regimen for this drug.
Potential Side Effects[edit | edit source]
As with any drug, PRX-08066 has the potential to cause side effects. These can include nausea, vomiting, headache, and dizziness. However, these side effects are generally mild and manageable. More serious side effects can include changes in heart rate, blood pressure, and liver function. Patients taking PRX-08066 should be closely monitored for these potential side effects.
See Also[edit | edit source]
| PRX-08066 Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
